Fractyl Health Inc
Research Fractyl Health Inc (GUTS) on Bullrun: market cap USD 126.22M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGUTS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 126.22M
- Financial periodFY2025
- Revenue growth-100.0%
- Net income-USD 140.95M
- Free cash flow-USD 90.89M
Valuation Snapshot
latest market cap is USD 126.22M.
About Fractyl Health Inc
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Frequently asked questions
What is Fractyl Health Inc's market cap?
Fractyl Health Inc's market capitalization is USD 126.22M.
What does Fractyl Health Inc do?
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.